ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
0,00
0,00%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,145
0,02%
Bitcoin
64 139,18
0,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NeuroMetrix Inc (NURO)

  7. NeuroMetrix Inc (NURO) Actualités

NURO NeuroMetrix Inc

4,55
0,08 (1,79%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NeuroMetrix Inc NURO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,08 1,79% 4,55 06:00:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,45 4,28 4,45 4,30 4,47
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/4/202414:00GLOBENeuroMetrix Announces Steps Taken to Enhance Shareholder..
14/3/202414:00GLOBENeuroMetrix Announces Publication of Study Demonstrating..
13/3/202414:00GLOBENeuroMetrix announces that over 2000 patients with..
06/3/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:12EDGAR2Form SC 13D/A - General statement of acquisition of..
01/3/202423:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202422:45EDGAR2Form 8-K/A - Current report: [Amend]
27/2/202422:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/2/202423:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/2/202413:15EDGAR2Form 8-K - Current report
22/2/202413:00GLOBENeuroMetrix Reports Q4 and Full Year 2023 Business..
20/2/202420:49EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/2/202415:00GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
13/2/202415:00GLOBENeuroMetrix Announces Review of Strategic Options to Promote..
12/12/202315:00GLOBENeuroMetrix Reports Encouraging Results from Pilot Clinical..
05/12/202315:00GLOBENeuroMetrix Announces Peer-Reviewed Publication of Phase 2..
20/11/202315:33EDGAR2Form 8-K - Current report
20/11/202315:00GLOBENeuroMetrix Announces One-for-Eight Reverse Stock Split
26/10/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202313:11EDGAR2Form 8-K - Current report
26/10/202313:00GLOBENeuroMetrix Reports Q3 2023 Business Highlights
23/10/202317:13GLOBENeuroMetrix, Inc. Announces Date for Third Quarter 2023..
20/10/202320:59EDGAR2Form 8-K - Current report
02/10/202315:00GLOBENeuroMetrix and the National Fibromyalgia Association to..
11/9/202313:59EDGAR2Form DEF 14A - Other definitive proxy statements
11/8/202323:11EDGAR2Form 8-K - Current report
05/8/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202300:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202323:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202322:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/7/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202313:24EDGAR2Form 8-K - Current report
27/7/202313:00GLOBENeuroMetrix Reports Q2 2023 Business Highlights
20/7/202319:00GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2023..
11/7/202315:00GLOBENeuroMetrix Announces Sales Force Expansion for Quell..
28/6/202315:00GLOBERecent Publications Demonstrate Utility of DPNCheck® for..
07/6/202315:00GLOBEDiabetic Peripheral Neuropathy Screening That Includes..
31/5/202315:00GLOBEQuell® Demonstrates Encouraging Clinical Trial Results in..

Dernières Valeurs Consultées

NASDAQ
NURO
NeuroMetrix
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés